Workflow
海正生材: 浙江海正生物材料股份有限公司关于调整回购股份价格上限及延长实施期限的公告

Core Viewpoint - Zhejiang Haizheng Biomaterials Co., Ltd. has announced an adjustment to its share repurchase plan, increasing the maximum repurchase price from 12 RMB per share to 17 RMB per share and extending the implementation period by 6 months until February 27, 2026 [1][3]. Summary by Sections 1. Basic Information on Share Repurchase - The company plans to repurchase its issued A-shares using its own funds through the Shanghai Stock Exchange, initially set at a maximum price of 12 RMB per share and a total repurchase fund between 20 million RMB and 30 million RMB [1][2]. 2. Progress of Share Repurchase - As of the disclosure date, the company has repurchased a total of 1,482,364 shares, accounting for approximately 0.73% of the total share capital of 202,678,068 shares, with a total expenditure of approximately 14.29 million RMB [3]. 3. Reasons for Adjusting the Repurchase Plan - The adjustment to the repurchase price and extension of the implementation period are due to the recent increase in the company's stock price, which exceeded the previously set maximum repurchase price. This change aims to ensure the smooth execution of the repurchase plan and protect shareholder interests [3][4]. 4. Rationality and Necessity of the Adjustment - The adjustment complies with relevant regulations and is based on market conditions and the progress of the repurchase. The new maximum price is set at 150% of the average trading price over the last 30 trading days prior to the board's decision [3][4]. 5. Decision-Making Process for the Adjustment - The adjustment was approved by the company's seventh board of directors' seventeenth meeting, with all directors present. This matter does not require submission to the shareholders' meeting for approval [5].